CHRISTOPHER O'BRIEN: Open Payments
NPI 1780225623 · NORTH SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 28 payments from 15 companies in 2025. Trend: 2023 $758 · 2024 $720 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $93 |
| Travere Therapeutics, Inc. | 2 | $53 |
| Amgen Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Abbott Laboratories | 2 | $44 |
| Novo Nordisk Inc | 2 | $44 |
| Calliditas Therapeutics US Inc. | 2 | $43 |
| ANI Pharmaceuticals, Inc. | 2 | $41 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $31 |
Products named: Fabhalta, Kerendia, TAVNEOS, JARDIANCE, TARPEYO, PURIFIED CORTROPHIN GEL, IBSRELA, Ozempic.
Industry payments across NY — which companies pay providers there.
